Serum YKL-40 predicts relapse-free and overall survival in patients with American Joint Committee on Cancer stage I and II melanoma (Q82161711)
Jump to navigation
Jump to search
scientific article published on 03 January 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Serum YKL-40 predicts relapse-free and overall survival in patients with American Joint Committee on Cancer stage I and II melanoma |
scientific article published on 03 January 2006 |
Statements
Serum YKL-40 predicts relapse-free and overall survival in patients with American Joint Committee on Cancer stage I and II melanoma (English)
Henrik Schmidt
Julia S Johansen
Pia Sjoegren
Ib J Christensen
Kirsten Fode
Jorn Larsen
Hans von der Maase
3 January 2006